Chronic rhinosinusitis (CRS) is a surprisingly common but under-recognized disease that affects nearly one billion people ...

Does your nose seem to always be stuffed up? Do you have loss of taste or smell? Do you get frequent sinus infections? If so, you may have nasal polyps. Which raises the question: What exactly are ...

Nasal polyps are soft, non-cancerous growths in the nasal or sinus lining, often linked to chronic rhinosinusitis, asthma, allergies, and aspirin intolerance. They cause nasal obstruction, loss of ...

You might be tempted to ignore symptoms like congestion, runny nose, and itchy eyes, thinking they're due to seasonal allergies or a cold. And most often, they are. But if they last for a long time, ...

Do you ever feel like you're stuck with a perpetual stuffy nose, no matter the time of year or how many tissues you go through? It's like your nose is constantly congested, and you're forced to ...

Dear Dr. Roach: I have suffered from asthma and nasal polyps for more than 20 years. The asthma is controlled, and I mention it only because it might have some connection with my polyps. The polyps ...

The first head-to-head randomized clinical trial to compare biologics in severe chronic rhinosinusitis with nasal polyps ...

A study of the nasal microbiome helped researchers predict recurrent polyps in chronic rhinosinusitis patients with more than 90% accuracy, based on data from 85 individuals. Chronic rhinosinusitis ...

The nose is the subject of many sayings. A measurement could be on the nose or an object right under your nose. You may be reminded to keep your nose clean and out of another’s affairs. While often ...

Tezspire (tezepelumab) has received a positive opinion from the CHMP for the treatment of chronic rhinosinusitis with nasal ...

Amgen Inc. (NASDAQ:AMGN) is one of the Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 22, Amgen ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive topline data from two Phase III multicenter studies ...